Australian Life Scientist
June 6, 2004 by admin
Filed under Media Reports, Media Reports 2004
| CRO Novotech springboards into US Australian CRO Novotech is setting up operations in the US to take advantage of the clinical trials opportunities offered there. “There is a natural ceiling in Australia for the size of clinical trials, due to our [small] population. We’re expanding offshore so that we can do larger trials — primarily in the US,” said CEO Alek Safarian at last week’s BIO 2004 conference at San Francisco. |
For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote #1003  |
